BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Prognosis
17 results:

  • 1. The role of transcription factor FOXA1/C2/M1/O3/P1/Q1 in breast cancer.
    Yuan H; Liang Y; Hu S; Chen J; You J; Jiang J; Luo M; Zeng M
    Medicine (Baltimore); 2024 Apr; 103(15):e37709. PubMed ID: 38608123
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting the purinergic pathway in breast cancer and its therapeutic applications.
    de Araújo JB; Kerkhoff VV; de Oliveira Maciel SFV; de Resende E Silva DT
    Purinergic Signal; 2021 Jun; 17(2):179-200. PubMed ID: 33576905
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
    Harada H; Soeno T; Nishizawa N; Washio M; Sakuraya M; Ushiku H; Niihara M; Hosoda K; Kumamoto Y; Naitoh T; Sangai T; Hiki N; Yamashita K
    Cancer Sci; 2021 Apr; 112(4):1644-1654. PubMed ID: 33576114
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Detection of Circulating Tumor Cells in breast cancer Patients by Nanopore Sensing with Aptamer-Mediated Amplification.
    Li X; Zhang P; Dou L; Wang Y; Sun K; Zhang X; Song G; Zhao C; Li K; Bai Y; Zeng X; Zhou C; Ying B; Chen J; Geng J
    ACS Sens; 2020 Aug; 5(8):2359-2366. PubMed ID: 32388982
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [breast cancer management before 40 years: what change in one decade? A retrospective study at the "Institut de cancérologie de Lorraine": 2002-2012].
    Soussoko M; Salleron J; Desandes E; Lesur A
    Bull Cancer; 2019 Dec; 106(12S1):S60-S74. PubMed ID: 32008740
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.
    Lee SB; Ko SS; Park CH; Nam SJ; Choi JE; Jung YS; Park WC; Son BH
    Breast Cancer Res Treat; 2018 Nov; 172(2):273-282. PubMed ID: 30088179
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
    Yang SJ; Wang DD; Li J; Xu HZ; Shen HY; Chen X; Zhou SY; Zhong SL; Zhao JH; Tang JH
    Gene; 2017 Aug; 623():5-14. PubMed ID: 28438694
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Human glutathione S-transferase P1-1 functions as an estrogen receptor α signaling modulator.
    Liu X; An BH; Kim MJ; Park JH; Kang YS; Chang M
    Biochem Biophys Res Commun; 2014 Sep; 452(3):840-4. PubMed ID: 25218501
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.
    Shigekawa T; Ijichi N; Ikeda K; Horie-Inoue K; Shimizu C; Saji S; Aogi K; Tsuda H; Osaki A; Saeki T; Inoue S
    Horm Cancer; 2011 Oct; 2(5):286-97. PubMed ID: 21901488
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HLA class-II allele frequencies in Turkish breast cancer patients.
    Gun FD; Ozturk OG; Polat A; Polat G
    Med Oncol; 2012 Jun; 29(2):466-71. PubMed ID: 21373933
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation.
    Montano X
    Oncogene; 2009 Oct; 28(43):3787-800. PubMed ID: 19749791
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. FOXP1: a potential therapeutic target in cancer.
    Koon HB; Ippolito GC; Banham AH; Tucker PW
    Expert Opin Ther Targets; 2007 Jul; 11(7):955-65. PubMed ID: 17614763
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Association of GSTP1 CpG islands hypermethylation with poor prognosis in human breast cancers.
    Arai T; Miyoshi Y; Kim SJ; Taguchi T; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2006 Nov; 100(2):169-76. PubMed ID: 16791478
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. TLK-286: a novel glutathione S-transferase-activated prodrug.
    Tew KD
    Expert Opin Investig Drugs; 2005 Aug; 14(8):1047-54. PubMed ID: 16050796
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1alpha/CXCL12.
    Kishimoto H; Wang Z; Bhat-Nakshatri P; Chang D; Clarke R; Nakshatri H
    Carcinogenesis; 2005 Oct; 26(10):1706-15. PubMed ID: 15917309
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. TLK 286.
    Drugs R D; 2004; 5(2):116-8. PubMed ID: 15293875
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [breast carcinomas and the extracellular matrix].
    Clavel C; Birembaut P; Adnet JJ; Foidart JM
    Ann Pathol; 1988; 8(2):107-13. PubMed ID: 3041983
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.